
Today’s Yangtze funding roundup: Medical AI, drug discovery, AI infrastructure
SenseCare tops 10 billion yuan in valuation, while AI drug discovery, digital pathology and AI infrastructure startups secure new funding.

SenseCare tops 10 billion yuan in valuation, while AI drug discovery, digital pathology and AI infrastructure startups secure new funding.